Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 14401-14450 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT06156111
Bacterial Microleakage and Bone Loss in Internal Connection Dental Implants Based on the Type of Abutment Used in Zirconia Partial Fixed Prosthesis: in Vivo Study
NAActive, not recruiting
20 participants
Started: Feb 26, 2020 · Completed: Nov 30, 2023
1 condition1 sponsor1 location
NCT04018053
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
EARLY_PHASE1Active, not recruiting
16 participants
Started: Feb 26, 2020 · Completed: Dec 30, 2025
2 conditions2 sponsors1 location
NCT04084080
Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
PHASE3Active, not recruiting
173 participants
Started: Feb 26, 2020 · Completed: May 31, 2026
1 condition2 sponsors23 locations
NCT04214392
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
PHASE1Active, not recruiting
19 participants
Started: Feb 26, 2020 · Completed: Jun 9, 2026
4 conditions2 sponsors1 location
NCT04068753
Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer
PHASE2Active, not recruiting
66 participants
Started: Feb 26, 2020 · Completed: Jul 31, 2027
2 conditions2 sponsors4 locations
NCT04291859
Lu AF28996 in Participants With Parkinson's Disease (PD)
PHASE1Active, not recruiting
57 participants
Started: Feb 26, 2020 · Completed: Feb 4, 2026
1 condition1 sponsor15 locations
NCT04428866
Mechanisms of Post-Bariatric Hypoglycemia
N/AActive, not recruiting
105 participants
Started: Feb 26, 2020 · Completed: Sep 30, 2024
1 condition2 sponsors1 location
NCT04222556
Evaluation of Thiwáhe Gluwáš'Akapi Substance Use Prevention Program
NAActive, not recruiting
552 participants
Started: Feb 26, 2020 · Completed: Feb 28, 2025
3 conditions2 sponsors1 location
NCT04328844
A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
PHASE1Active, not recruiting
210 participants
Started: Feb 25, 2020 · Completed: Mar 31, 2025
5 conditions1 sponsor3 locations
NCT04127006
Rate of Progression in EYS Related Retinal Degeneration
N/AActive, not recruiting
103 participants
Started: Feb 25, 2020 · Completed: Dec 31, 2025
2 conditions2 sponsors19 locations
NCT04160494
D2C7-IT With Atezolizumab for Recurrent Gliomas
PHASE1Active, not recruiting
18 participants
Started: Feb 25, 2020 · Completed: Dec 31, 2027
1 condition4 sponsors1 location
NCT04030559
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects
PHASE2Active, not recruiting
11 participants
Started: Feb 25, 2020 · Completed: Dec 31, 2025
17 conditions3 sponsors1 location
NCT03938389
The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans
PHASE4Active, not recruiting
90 participants
Started: Feb 25, 2020 · Completed: Jun 30, 2026
4 conditions2 sponsors1 location
NCT04228172
Genotypic Influences on Network Progression in Parkinson's Disease
N/AActive, not recruiting
32 participants
Started: Feb 24, 2020 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT04215952
Semantic Feature Analysis Treatment for Aphasia
NAActive, not recruiting
40 participants
Started: Feb 24, 2020 · Completed: Aug 30, 2025
1 condition2 sponsors1 location
NCT04221295
The PREPARE Trial: Exercise Before Surgery to Improve Recovery in Older People With Frailty
NAActive, not recruiting
850 participants
Started: Feb 24, 2020 · Completed: May 30, 2025
3 conditions1 sponsor1 location
NCT04267705
Pulses Consumption and Its Role in Managing Systemic Inflammation, Insulin Sensitivity and Gut Microbiome in Human
NAActive, not recruiting
103 participants
Started: Feb 24, 2020 · Completed: Jan 30, 2026
3 conditions2 sponsors1 location
NCT04158258
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
N/AActive, not recruiting
2,907 participants
Started: Feb 21, 2020 · Completed: Jun 30, 2026
1 condition2 sponsors30 locations
NCT04273854
Physician Optimised Post-partum Hypertension Treatment Trial
NAActive, not recruiting
200 participants
Started: Feb 21, 2020 · Completed: Dec 1, 2030
2 conditions2 sponsors2 locations
NCT04108195
A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma
PHASE1Active, not recruiting
290 participants
Started: Feb 21, 2020 · Completed: Apr 7, 2027
1 condition1 sponsor24 locations
NCT04684706
Compressed Intermittent Theta Burst Stimulation
NAActive, not recruiting
40 participants
Started: Feb 20, 2020 · Completed: Dec 20, 2025
1 condition1 sponsor2 locations
NCT06082882
Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 2
NAActive, not recruiting
8,000 participants
Started: Feb 20, 2020 · Completed: Aug 31, 2025
2 conditions2 sponsors1 location
NCT04257461
A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma
PHASE3Active, not recruiting
30 participants
Started: Feb 20, 2020 · Completed: Dec 31, 2025
1 condition3 sponsors9 locations
NCT04239794
The Influence of Type of Anesthesia on Postoperative Pain
NAActive, not recruiting
468 participants
Started: Feb 20, 2020 · Completed: Jan 31, 2024
2 conditions1 sponsor3 locations
NCT03919071
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
PHASE2Active, not recruiting
58 participants
Started: Feb 20, 2020 · Completed: Sep 30, 2027
8 conditions1 sponsor131 locations
NCT04284228
Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT
PHASE1/PHASE2Active, not recruiting
22 participants
Started: Feb 20, 2020 · Completed: Mar 31, 2025
2 conditions1 sponsor5 locations
NCT04137159
An Exercise Intervention to Reduce Neuropathic Pain and Brain Inflammation After Spinal Cord Injury
NAActive, not recruiting
13 participants
Started: Feb 20, 2020 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT04256850
Teaching Novel Values-Based Skills to Improve Long-Term Weight Loss
NAActive, not recruiting
480 participants
Started: Feb 19, 2020 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05139888
Light Therapy for Onychomycosis Study
NAActive, not recruiting
100 participants
Started: Feb 19, 2020 · Completed: Dec 19, 2024
1 condition1 sponsor1 location
NCT04115553
Assessment of Venous Drainage in Idiopathic Intracranial Hypertension
NAActive, not recruiting
60 participants
Started: Feb 19, 2020 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT04428736
Evaluating Cascade Communication Methods
N/AActive, not recruiting
100 participants
Started: Feb 19, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03932409
Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer
PHASE1Active, not recruiting
45 participants
Started: Feb 19, 2020 · Completed: Feb 28, 2026
1 condition2 sponsors2 locations
NCT04112641
NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy
PHASE2Active, not recruiting
48 participants
Started: Feb 19, 2020 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT04178005
Cladribine Tablets After Treatment With Natalizumab (CLADRINA)
PHASE4Active, not recruiting
40 participants
Started: Feb 19, 2020 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT04231851
CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia
PHASE2Active, not recruiting
30 participants
Started: Feb 19, 2020 · Completed: Jun 30, 2027
2 conditions3 sponsors4 locations
NCT04081779
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
NAActive, not recruiting
258 participants
Started: Feb 19, 2020 · Completed: Dec 31, 2025
5 conditions2 sponsors1 location
NCT03884257
A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon.
NAActive, not recruiting
302 participants
Started: Feb 18, 2020 · Completed: Sep 30, 2026
1 condition1 sponsor14 locations
NCT04231539
Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study
NAActive, not recruiting
20 participants
Started: Feb 18, 2020 · Completed: Aug 18, 2024
1 condition2 sponsors1 location
NCT04259138
Determination of the Optimal Treatment Target in Ulcerative Colitis
PHASE4Active, not recruiting
672 participants
Started: Feb 18, 2020 · Completed: Mar 31, 2026
1 condition2 sponsors58 locations
NCT04205227
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
PHASE1/PHASE2Active, not recruiting
137 participants
Started: Feb 18, 2020 · Completed: Mar 31, 2026
5 conditions2 sponsors5 locations
NCT04259398
Anesthesia and Cancer Study: Colon Cancer
NAActive, not recruiting
797 participants
Started: Feb 18, 2020 · Completed: May 3, 2028
2 conditions6 sponsors2 locations
NCT04147013
Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS
PHASE4Active, not recruiting
44 participants
Started: Feb 18, 2020 · Completed: Jul 31, 2026
2 conditions3 sponsors2 locations
NCT04223102
Microbiome and Rectal Cancer
NAActive, not recruiting
40 participants
Started: Feb 18, 2020 · Completed: Jun 30, 2027
2 conditions1 sponsor3 locations
NCT03961971
Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
PHASE1Active, not recruiting
16 participants
Started: Feb 18, 2020 · Completed: Sep 30, 2026
1 condition2 sponsors2 locations
NCT04004442
Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma
PHASE1Active, not recruiting
19 participants
Started: Feb 17, 2020 · Completed: Sep 30, 2025
1 condition3 sponsors1 location
NCT04194944
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
PHASE3Active, not recruiting
261 participants
Started: Feb 17, 2020 · Completed: Jun 30, 2030
1 condition2 sponsors196 locations
NCT04009044
Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast
PHASE2Active, not recruiting
156 participants
Started: Feb 17, 2020 · Completed: Jun 25, 2026
3 conditions2 sponsors2 locations
NCT04257136
VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients
PHASE2Active, not recruiting
20 participants
Started: Feb 17, 2020 · Completed: Dec 31, 2023
3 conditions1 sponsor8 locations
NCT04660708
Manual Physical Therapy During Pregnancy on Post Partum Perineal Trauma and Pain
NAActive, not recruiting
105 participants
Started: Feb 15, 2020 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT04293185
A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease
PHASE3Active, not recruiting
35 participants
Started: Feb 14, 2020 · Completed: Nov 30, 2027
1 condition1 sponsor9 locations